Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lois E Smith"'
Autor:
Andrew Kuo, Antonio Checa, Colin Niaudet, Bongnam Jung, Zhongjie Fu, Craig E Wheelock, Sasha A Singh, Masanori Aikawa, Lois E Smith, Richard L Proia, Timothy Hla
Publikováno v:
eLife, Vol 11 (2022)
Serine palmitoyl transferase (SPT), the rate-limiting enzyme in the de novo synthesis of sphingolipids (SL), is needed for embryonic development, physiological homeostasis, and response to stress. The functions of de novo SL synthesis in vascular end
Externí odkaz:
https://doaj.org/article/e21f8001eecc472486c15e1a9e2ebd82
Autor:
Pia Lundgren, Elisabeth Stoltz Sjöström, Magnus Domellöf, Karin Källen, Gerd Holmström, Anna-Lena Hård, Lois E Smith, Chatarina Löfqvist, Ann Hellström
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e73256 (2013)
To evaluate the ability of a postnatal weight-gain algorithm (WINROP) to identify sight-threatening retinopathy of prematurity (ROP type 1) in a nation-based extremely preterm infant cohort.This study enrolled all 707 live-born extremely preterm (ges
Externí odkaz:
https://doaj.org/article/946640cff5c6478fb32075d6fe2c1e75
Autor:
Tadanori Mammoto, Jing Chen, Elisabeth Jiang, Amanda Jiang, Lois E Smith, Donald E Ingber, Akiko Mammoto
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41596 (2012)
Angiogenesis is crucial for lung development. Although there has been considerable exploration, the mechanism by which lung vascular and alveolar formation is controlled is still not completely understood. Here we show that low-density lipoprotein re
Externí odkaz:
https://doaj.org/article/4f7ef93707754b3e880895c1a5a7bea1
Autor:
Andrew Kuo, Antonio Checa, Colin Niaudet, Bongnam Jung, Zhongjie Fu, Craig E Wheelock, Sasha A Singh, Masanori Aikawa, Lois E Smith, Richard L Proia, Timothy Hla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e5ac2ba83b1bd9fb0dbd9b440ca1b60
https://doi.org/10.7554/elife.78861.sa2
https://doi.org/10.7554/elife.78861.sa2
Autor:
Pia Lundgren, Eva Morsing, Anna‐Lena Hård, Alexander Rakow, Lena Hellström‐Westas, Lena Jacobson, Mats Johnson, Gerd Holmström, Staffan Nilsson, Lois E. Smith, Karin Sävman, Ann Hellström
Publikováno v:
Acta paediatrica (Oslo, Norway : 1992). 111(8)
Aim To describe survival and neonatal morbidities in infants born before 24 weeks of gestation during a 12-year period. Methods Data were retrieved from national registries and validated in medical files of infants born before 24 weeks of gestation 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f403ab3cb5413d6dcf841efe7dc080d
https://pubmed.ncbi.nlm.nih.gov/35527403
https://pubmed.ncbi.nlm.nih.gov/35527403
Autor:
Andrew Kuo, Antonio Checa, Colin Niaudet, Bongnam Jung, Zhongjie Fu, Craig E. Wheelock, Sasha A. Singh, Masanori Aikawa, Lois E. Smith, Richard L. Proia, Timothy Hla
Serine palmitoyl transferase (SPT), the rate-limiting enzyme in the de novo synthesis of sphingolipids (SL), is needed for embryonic development, physiological homeostasis, and response to stress. The functions of de novo SL synthesis in vascular end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::036f38b5d38e086c30606d75fa2c3607
https://doi.org/10.1101/2022.03.22.485296
https://doi.org/10.1101/2022.03.22.485296
Autor:
M Elizabeth, Hartnett, David K, Wallace, Trevano W, Dean, Zhuokai, Li, Charline S, Boente, Eniolami O, Dosunmu, Sharon F, Freedman, Richard P, Golden, Lingkun, Kong, S Grace, Prakalapakorn, Michael X, Repka, Lois E, Smith, Haibo, Wang, Raymond T, Kraker, Susan A, Cotter, Jonathan M, Holmes
Publikováno v:
JAMA Ophthalmol
IMPORTANCE: Intravitreal bevacizumab effectively treats severe retinopathy of prematurity (ROP), but it enters the bloodstream and may reduce serum vascular endothelial growth factor (VEGF), potentially causing detrimental effects on developing organ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::18bb2e3e1a43afeedd18e0dfccbb569f
https://europepmc.org/articles/PMC8895318/
https://europepmc.org/articles/PMC8895318/
Autor:
William V. Good, Michael B. Yang, Trevano W. Dean, Jonathan M. Holmes, David K. Wallace, Amit R. Bhatt, Kathryn M. Haider, Susan A. Cotter, R. Michael Siatkowski, Eric R. Crouch, Sharon F. Freedman, David L. Rogers, Lois E. Smith, Roy W. Beck, Lingkun Kong, M. Elizabeth Hartnett, Michael X. Repka, Amy K. Hutchinson, Deborah K. VanderVeen, Raymond T. Kraker
Publikováno v:
JAMA Ophthalmol
Importance Intravitreous bevacizumab (0.25 mg to 0.625 mg) is commonly used to treat type 1 retinopathy of prematurity (ROP), but there are concerns about systemic toxicity, particularly the risk of neurodevelopmental delay. A much lower dose may be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::893e6b40031e516bc3b0b499844d8ca5
https://europepmc.org/articles/PMC7180729/
https://europepmc.org/articles/PMC7180729/
Publikováno v:
Clinics in perinatology. 40(2)
Retinopathy of prematurity occurs because the retina of a preterm infant at birth is incompletely vascularized, and if the postnatal environment does not match the in utero environment that supported retinal development, the vessels and neural retina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3ec5a9bce574712f35676afc1e753923
https://pubmed.ncbi.nlm.nih.gov/23719305
https://pubmed.ncbi.nlm.nih.gov/23719305